Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2002
View Archived Issues
Potential use of botulinum toxin A in the treatment of wrist spasticity following stroke
Read More
Enhanced p53-specific T-cell immunity found in colorectal cancer patients treated with ALVAC-p53
Read More
Potential use of LFM-A13 against chemotherapy-resistant B cell lymphomas or leukemias
Read More
FDA accepts MethyPatch NDA
Read More
Allos Therapeutics examines potential of RSR-13 in locally advanced cervical cancer
Read More
ISAtx-247 is a more effective immunosuppressant than ciclosporin in cynomolgus monkeys
Read More
Renal vasoconstriction induced by tacrolimus in rats is prevented by low dose theophylline
Read More
Selective inhibition of Rho-associated protein kinase attenuates hepatic ischemia/reperfusion injury
Read More
Effects of bimosiamose on renal preservation injury in a canine transplant model
Read More
EP4 selective agonists for treatment of skeletal disorders reported by Pfizer
Read More
Berlex reports a new series of CCR1 antagonists at the recent ACS meeting
Read More
Aerosol tacrolimus prevents acute pulmonary allograft rejection in a rat lung allograft model
Read More
Merck Frosst describes a new series of potent PDE4 inhibitors
Read More
Pivotal program protocol for T-67 approved by FDA
Read More
Crucell and Johns Hopkins sign cooperative agreement for antibodies against LCH
Read More
E.U. approval for Aranesp
Read More
MedImmune responds to Flumist complete response letter
Read More
Subanalysis of SnET2 phase III data
Read More
Dyax initiates phase I/II trial of DX-88 in cardiopulmonary bypass patients
Read More
Potent and selective MMP inhibitors designed at Pharmacia
Read More
Scientists at Genzyme identify novel compounds that modulate TNF-alpha signaling
Read More
Muscarinic M3 receptor antagonists disclosed by Almirall Prodesfarma
Read More
Farnesyl protein transferase-inhibiting compounds claimed by Janssen
Read More
PPAR modulators for use as hypoglycemics and lipid-lowering agents
Read More
DPP-IV inhibitors with utility in type 2 diabetes and associated complications
Read More
Daiichi Pharmaceutical prepares CDK4 inhibitors
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe